Home
>
National Drug Code (NDC)
>
ZOLADEX
ZOLADEX - 0310-0950-36 - (Goserelin acetate)
Drug Information of ZOLADEX
| Product NDC: | 0310-0950 |
| Proprietary Name: | ZOLADEX |
| Non Proprietary Name: | Goserelin acetate |
| Active Ingredient(s): | 3.6 mg/1 & nbsp; Goserelin acetate |
| Administration Route(s): | SUBCUTANEOUS |
| Dosage Form(s): | IMPLANT |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of ZOLADEX
| Product NDC: | 0310-0950 |
| Labeler Name: | AstraZeneca Pharmaceuticals LP |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA019726 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20030505 |
Package Information of ZOLADEX
| Package NDC: | 0310-0950-36 |
| Package Description: | 1 POUCH in 1 CARTON (0310-0950-36) > 1 SYRINGE in 1 POUCH > 1 IMPLANT in 1 SYRINGE |
NDC Information of ZOLADEX
| NDC Code | 0310-0950-36 |
| Proprietary Name | ZOLADEX |
| Package Description | 1 POUCH in 1 CARTON (0310-0950-36) > 1 SYRINGE in 1 POUCH > 1 IMPLANT in 1 SYRINGE |
| Product NDC | 0310-0950 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Goserelin acetate |
| Dosage Form Name | IMPLANT |
| Route Name | SUBCUTANEOUS |
| Start Marketing Date | 20030505 |
| Marketing Category Name | NDA |
| Labeler Name | AstraZeneca Pharmaceuticals LP |
| Substance Name | GOSERELIN ACETATE |
| Strength Number | 3.6 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Gonadotropin Releasing Hormone Receptor Agonist [EPC],Gonadotropin Releasing Hormone Receptor Agonists [MoA] |
